HomeVTGN • NASDAQ
add
Vistagen Therapeutics Inc
Previous close
$0.55
Day range
$0.43 - $0.52
Year range
$0.43 - $5.14
Market cap
19.79M USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 303.00K | 29.49% |
Operating expense | 19.85M | 29.28% |
Net income | -18.90M | -34.14% |
Net profit margin | -6.24K | -3.59% |
Earnings per share | -0.45 | 2.17% |
EBITDA | -19.49M | -29.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.77M | -30.25% |
Total assets | 65.06M | -29.52% |
Total liabilities | 14.14M | 26.38% |
Total equity | 50.92M | — |
Shares outstanding | 39.62M | — |
Price to book | 0.42 | — |
Return on assets | -66.95% | — |
Return on capital | -81.07% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -18.90M | -34.14% |
Cash from operations | -17.63M | -71.51% |
Cash from investing | 104.00K | 124.64% |
Cash from financing | 2.11M | 80.36% |
Net change in cash | -15.42M | -61.74% |
Free cash flow | -11.63M | -123.56% |
About
Founded
1998
Headquarters
Website
Employees
59
